A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain malignancy known for its fast growth and insensitivity to standard treatments. Studies are read more constantly underway to identify new treatment strategies, and recently, a unique biomarker named LCA168 has emerged as a potential target for GBM treatment. LCA168 is a protein that is highly expressed in glioblast